Search Results

Effects of iron supplementation on microcytic and hypochromic red blood cells during the third trimester of pregnancy.

• Authors : Schoorl, Margreet; Schoorl, Marianne

Subjects: THERAPEUTIC use of iron; BIOMARKERS; HEMOGLOBINS

• Source: International Journal of Laboratory Hematology. Dec2022, Vol. 44 Issue 6, p1060-1067. 8p.

Record details

Addition of roxadustat to erythropoiesis‐stimulating agent (ESA) effectively corrects ESA‐hyporesponsive anaemia in patients on peritoneal dialysis.

• Authors : Dai, Shuqi; Chen, Yun; Hao, Chuanming

Subjects: COMBINATION drug therapy; HEMOGLOBINS; PERITONEAL dialysis

• Source: Journal of Clinical Pharmacy & Therapeutics. Oct2022, Vol. 47 Issue 10, p1525-1530. 6p.

Record details

The use of erythropoiesis‐stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib.

• Authors : Crisà, Elena^1,2 ; Cilloni, Daniela³; Elli, Elena M.⁴

Subjects: *ERYTHROPOIESIS; *ANEMIA treatment; *TREATMENT effectiveness

• Source: British Journal of Haematology. Sep2018, Vol. 182 Issue 5, p701-704. 4p. 1 Chart, 1 Graph.

Record details

Association between resistance to erythropoiesis‐stimulating agents and carnitine profile in patients on maintenance haemodialysis.

• Authors : Kamei, Daigo^1,2; Tsuchiya, Ken^1,2; Nitta, Kosaku^1,2

Subjects: *ERYTHROPOIESIS; *HEMODIALYSIS; *CARNITINE deficiency

• Source: Nephrology. Aug2018, Vol. 23 Issue 8, p737-743. 7p.

Record details

Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.

• Authors : Gummer, Joel¹; Trengove, Robert¹; Pascoe, Elaine M.²

Subjects: *HEPCIDIN; *ERYTHROPOIESIS; *KIDNEY diseases

• Source: Nephrology. Jul2017, Vol. 22 Issue 7, p548-554. 7p.

Record details

Correlation between haemoglobin level and type of erythropoiesis-stimulating agent at initiation of haemodialysis.

• Authors : Higashiura, Masaki; Ohya, Masaki; Tanaka, Yusuke

Subjects: HEMOGLOBINS; CARDIOVASCULAR disease related mortality; CHRONIC kidney failure

• Source: International Journal of Clinical Pharmacy; Apr2020, Vol. 42 Issue 2, p635-641, 7p

Record details

Update on erythropoiesis-stimulating agents.

• Authors : Goodnough, Lawrence Tim; Shander, Aryeh

Subjects: ERYTHROPOIESIS; ANEMIA; CLINICAL trials

• Source: Best Practice & Research: Clinical Anaesthesiology; Mar2013, Vol. 27 Issue 1, p121-129, 9p

Record details

Coût médical direct des agents stimulant l’érythropoïèse dans le traitement de l’anémie chez le patient insuffisant rénal chronique : revue de la littérature.

• Authors : Ranchon, Florence; Hédoux, Stéphanie; Laville, Maurice

Subjects: ANEMIA treatment; CHRONIC kidney failure; GLYCOPROTEIN hormones

• Source: Néphrologie & Thérapeutique; Apr2010, Vol. 6 Issue 2, p97-104, 8p

Record details

Erythropoiesis-stimulating agent hyporesponsiveness (Review Article).

• Authors : JOHNSON, DAVID W.¹ ; POLLOCK, CAROL A.²; MACDOUGALL, IAIN C.¹

Subjects: *ERYTHROPOIESIS; *ERYTHROPOIETIN; *DISEASES

• Source: Nephrology. Aug2007, Vol. 12 Issue 4, p321-330. 10p. 1 Diagram.

Record details

Underweight as a Risk Factor for Iron Depletion and Iron- Deficient Erythropoiesis among Young Women in Rural Areas of East Java, Indonesia.

• Authors : Sumarmi, Sri; Puspitasari, Nunik; Handajani, Retno

• Source: Malaysian Journal of Nutrition; 2016, Vol. 22 Issue 2, p219-232, 14p

Record details